Genmab — Oktober 2020

[E_L]

though after the stock's run-up over the past two hears, he sees risk-reward as "balanced" at current levels.

https://thefly.com/n.php?id=3183153

[kkjoel]

GB - har GS samtidigt køb/hold/sælg anbefaling?

[kkjoel]

Ok, den tog EL sig af

[E_L]

good morning

[kkjoel]

And good mornings to The ELectrician I didn't have a target from GS, so it must be quite an old (and ridiculously low) one, 1,112?! But classically executed, none the less: buy, buy, buy yourself (having a target of 1,112 and a price of 2,200.. so that makes a lot of sense) - THEN recommend buy to all others.

[kkjoel]

Must be extremely positive for GEN 2day w GS recommendation. AND NBI up 0,5% yday. Let'
s see...

[kkjoel]

All right, they didn't recommend buy, but they more than doubled the TP. Same, same....

[Solsen]

Har valgt at reducere lidt på GS analysen, der har holdt hånden under Genmab. Det ligner en blodig dag med lockdowns trusler og smittetal der skræmmer.

[Solsen]

Men håber at Genmab stiger

[SEACOP]

Peak March 2021. https://financhill.com/stock-forecast/GMAB-stock-prediction

[E_L]

Novartis (NVS) CEO, Vas Narasimham on Q3 2020 Results - Earnings Call Transcript https://seekingalpha.com/article/4381882-novartis-nvs-ceo-vas-narasimham-on-q3-2020-results-earnings-call-transcript?part=single

[Bulder]

Nice: "If you look at some of the estimates on what the B-cell market could look like over the next 10 years, there are some estimates that point us to 35% to 40% of the market."

[Solsen]

Thats a lot

[Bulder]

Lad os antage at det svarer til 4 mia $. 10% heraf er 400 mio $.

[E_L]

PRAC agenda: 5.3.4. Carfilzomib - KYPROLIS (CAP) - EMEA/H/C/003790/II/0045, Orphan
Applicant: Amgen Europe B.V.

Scope: Extension of existing indication to include combination of Kyprolis (carfilzomib) with
daratumumab and dexamethasone. As a consequence, sections 4.1, 4.2, 4.8 and 5.1 of the
SmPC are updated. The package leaflet is updated in accordance
Action: For adoption of PRAC RMP AR, PRAC RMP assessment overview and advice to CHMP

[Bulder]

Professor ærgrer sig over Medicinrådets afvisning af Dar MPV https://haematologisktidsskrift.dk/2-uncategorised/768-professor-aergrer-sig-over-medicinradets-afvisning-af-dar-mpv.html

[Helge_LarsenPI-redaktør]

Ses vi kl. 17? https://event.webinarjam.com/register/8/rp8nvfw

[Bulder]

Belamaf på dansk https://haematologisktidsskrift.dk/sygdomme/myeloma/761-fda-haster-myelomatose-middel-ud-pa-markedet.html

[Klarussen]

Køber i 2050,- vi er der snart

[E_L]

New trial - A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies https://www.clinicaltrials.gov/ct2/show/NCT04606381?term=rHuPH20&lupd_s=10%2F27%2F2020&draw=2&rank=1